Some new trans-dihydronarciclasine derivatives containing a 1,4-benzodioxane moiety were stereoselectively synthesised using our feasible and efficient method developed recently. These new phenanthridone alkaloid analogues were obtained in both racemic and optically active forms. High enantioselectivities (up to 99% ee) were achieved by applying (8S,9S)-9-amino(9-deoxy)epiquinine as an organocatalyst. Due to a side reaction, various methoxyphenanthridine regioisomers were also prepared which afforded further synthetic trans-dihydronarciclasine analogues modified in the ring A of the phenanthridone scaffold.
Introduction
Nowadays, hundreds of members of alkaloids are known, which have been isolated from the plants of Amaryllidaceae family. After recognising their anticancerous properties, more and more attention has been paid to their isolation and structural elucidation [1] . The alkaloids prepared from this plant family are divided into 12 groups according to their ring systems [2] . Among these diverse structures, the most potent antitumorous alkaloids can be found in the phenanthridone subgroup. Surprisingly, the detailed investigations of Amaryllidaceae alkaloids started only at the end of the nineteenth century, when Gerrard isolated lycorine (1, Fig. 1 ) from Narcissus
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pseudonarcissus in 1877 [3, 4] . Since then, several alkaloids have been obtained from various Amaryllidaceae plants including trans-dihydronarciclasine (2, Fig. 1 ) isolated by Pettit and co-workers from Zephyranthes candida in 1990 [5] . Compound 2 is the most potent natural anticancerous alkaloid among the Amaryllidaceae ones according to the data from National Cancer Institute (NCI, USA) [6] . Its 7-deoxy analogue (3, Fig. 1 ) was also isolated by Pettit and co-workers from Hymenocallis caribaea and Hymenocallis latifolia, in pure form, but its biological activity was found to be weaker than that of 2 [6] . This can be explained by the lack of hydroxyl group at the position A-7, similarly to the comparison of other representatives, such as pancratistatin (4) and 7-deoxypancratistatin (5) or narciclasine (6) and lycoricidine (7) (Fig. 1) [6] . Further structure-activity relationship studies have intensively been made to find more effective synthetic analogues, but the modifications rather touched the ring C of the phenanthridone skeleton [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] than its ring A [21] [22] [23] [24] [25] [26] [27] [28] .
Furthermore, the Amaryllidaceae alkaloids also showed significant antiviral effects. Thus, compound 1 has strong activity against herpes simplex 1 and varicella zoster DNA viruses [29] and against several RNA viruses, such as avian influenza virus (H5N1) [30] or SARS coronavirus [31] . It has also inhibitory effects against reverse transcriptase enzyme in the HIV-1 virus [32] . Besides, strong antiviral activities of some phenanthridone alkaloids including compounds 4, 6, and 7 were reported by Gabrielsen and coworkers [33, 34] . Very recently, trans-dihydronarciclasine, pancratistatin, and narciclasine have also been found to be active against Zika virus [35] .
Previously, the racemic [36] and the ent-forms of 3 [37] , as well as those of 2 [38, 39] , were stereoselectively synthesised using our facile and efficient process developed recently. Later, we also reported the highly stereoselective synthesis of a series of analogues of 2 substituted by alkyloxy groups (ethoxy and/or methoxy) in the aromatic ring [40] . In this work, focusing further on the modification of ring A of the phenanthridone scaffold by introducing a relatively rigid substituent, the stereoselective syntheses of some new trans-dihydronarciclasine analogues containing a 1,4-benzodioxane moiety ( Fig. 2) , such as 2,3,4-trihydroxy-1,3,4,4a,5,9,10,12b-octahydro [1, 4] dioxino[2,3-j]-phenanthridin-6(2H)-one (8), 2,3,4,7-tetrahydroxy-1,3,4,4a,5,9,10,12b-octahydro [1, 4] dioxino[2,3-j]-phenanthridin-6(2H)-one (9), 2,3,4-trihydroxy-7-methoxy-1,3,4,4a,5,9,10,12b-octahydro [1, 4] dioxino [2,3-j] phenanthridin-6(2H)-one (10) and 2,3,4-trihydroxy-11-methoxy-1,2,3,4,4a,8,9,12b-octahydro [1, 4] dioxino [2,3- i]phenanthridin-6(2H)-one (11), were described in both racemic and enantiopure forms.
Our modifying strategy related to ring A of the phenanthridone skeleton aimed at the methylenedioxy (-OCH 2 O-) structural part, a rigid functional group, in transdihydronarciclasine, because this molecule part may also be responsible for the anticancerous activity of this alkaloid. Thus, the homologous ethylenedioxy (-OCH 2 CH 2 O-) one was introduced into the aromatic ring to obtain new analogues for further structure-activity relationship studies.
Results and discussion
Similarly to our previous synthetic works [38] [39] [40] , the starting material was vanillin (12) , an inexpensive and readily available substance. As seen in Scheme 1, in the initial step, compound 12 was demethylated to 3,4-dihydroxybenzaldehyde (13) in dichloromethane by AlCl 3 and pyridine, using a known method [41] , in good yield (92%). Hydroxyvanillin (15) was also obtained from 12, but in this case, at first, it was selectively iodinated to 5-iodovanillin (14) [42] almost quantitatively, and then compound 14 was Fig. 2 Structures of trans-dihydronarciclasine derivatives containing a 1,4-benzodioxane moiety (8) (9) (10) (11) hydrolysed with 20% aqueous NaOH solution in presence of CuSO 4 [43] to give 15 in 64% yield. The dihydrobenzodioxine ring was formed with 1,2-dibromoethane in DMF, in the presence of K 2 CO 3 [44] to afford 2,3-dihydrobenzo[b] [1, 4] dioxine-6-carbaldehyde (16) and 8-methoxy-2,3-dihydrobenzo[b] [1, 4] dioxine-6-carbaldehyde (17) in good yield (63%). In the next step, acetone was condensed with these benzaldehyde derivatives 16 and 17 in the Claisen-Schmidt reaction applying a high excess of acetone in water and basic conditions (NaOH) to give 4-(2,3-dihydrobenzo[b] [1, 4] dioxin-6-yl)but-3-en-2-one (18) and 4-(8-methoxy-2,3-dihydrobenzo[b] [1, 4] dioxin-6-yl)but-3-en-2-one (19) in good yields (83 and 62%, respectively). Since dibenzylidene acetone derivatives may also be formed during this reaction, the pure products were obtained after distillation.
The first asymmetric centre of the title molecules was formed by Michael addition of nitromethane to compounds 18 and 19 to afford (
. These racemic representatives were prepared by using Peseke and co-workers' mild method (MeNO 2 , EtOH, K 2 CO 3 ) [45] in very good yields (75-86%). Moreover, this reaction allows an opportunity to obtain these intermediates in enantiomerically pure form.
The results of the enantioselective Michael addition are summarised in Table 1 . Using 20 mol % (8S,9S)-9-amino(9-deoxy)epiquinine (22) organocatalyst [46] [47] [48] [49] [50] [51] [52] [53] under conditions applied previously [39, 40] , the optically active nitropentanones (-)-20 and (-)-21 were prepared in good yield (67%) and excellent enantioselectivity (92-98% ee) after 7 days. The negative optical rotation values suggest, in accordance with our previous studies [39, 40] , that these new intermediates enable synthesising further entforms of natural alkaloid analogues.
Henceforth, only the syntheses of the optically active compounds are shown, but the racemic derivatives can be afforded in the same way. As seen in Scheme 2, the ring C was built by the Claisen-Henry reaction using ethyl
Scheme 1
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formate and dry sodium methoxide in anhydrous diethyl ether to give (-)-3-hydroxy-5-(2 0 ,3
in moderate yields (46-57%) after column chromatography or recrystallisation from ethyl acetate. Full diastereoselectivity was achieved in this cyclisation step which can be explained by the H-bond formation between the C-3 hydroxy and C-4 nitro groups (Fig. 3) , as described by Walker [54] and observed by us previously [36] [37] [38] [39] [40] . Prior to the reduction of the nitro group into the amino one, the carbonyl group of (-)-23 and (-)-24 was protected with ethylene glycol, in the presence of oxalic acid, in anhydrous acetonitrile to afford (?)-3-hydroxy-5-(2 0 ,3 
Then the oxo group of (-)-31 or (-)-32 was stereoselectively reduced with NaBH 4 , in the presence of CaCl 2 , in methanol (Utimoto's method [57] ) to obtain (-)-6-(2
in good yields (67-79%) and excellent enantiopurity ([ 99% ee) after recrystallisation from hexane/ethyl acetate (2:1). This very high stereoselectivity was achieved with an axial attack of the small hydride ion derived from NaBH 4 enhanced by the coordination with Ca 2? , resulting in an equatorial position of the hydroxy group formed newly (Scheme 3). However, the structure of the title compounds requires the inversion of this asymmetry centre. For this purpose, the Mitsunobu reaction [58] (triphenylphosphine, diethyl azodicarboxylate, anhydrous THF) seemed to be an obvious choice. Thus, compound (-)-33 or (-)-34 was converted to (?)-5-(2 0 ,3 
, in excellent yields (99-100%). Prior to the Bischler-Napieralski cyclisation modified by Banwell and co-workers [60] , the hydroxy groups of (?)-37 or (?)-38 were protected by acetyl chloride to afford As seen in Scheme 4, the acidic treatment of (-)-41 with 2 M HCl in THF afforded (-)-2-benzoyloxy-6-oxo-1,2,3,4,4a,9,10,12b-octahydro [1, 4] 
] in moderate yield (54%), which was subsequently deacylated by the Zemplén's method [61] (NaOMe/MeOH) in THF to give the title compound (-)-8 in good yield (71%).
In the next reactions the racemic form of (±)-42 and (±)-43 was used, but the same results could be obtained by applying their optically active ones. When the 1:1 mixture of regioisomers (±)-42 and (±)-43 was quantitatively converted into lactams, such as (±)-2-benzoyloxy-7-methoxy-6-oxo-1,2,3,4,4a,8,9,12b-octahydro [1, 4] 
] and (±)-2-benzoyloxy-11-methoxy-6-oxo-1,2,3,4,4a,8,9,12b-octahydro [1, 4] 
, in the same way (Scheme 5), the methyl group of 7-methoxy derivative (±)-45 was selectively cleaved with iodotrimethylsilane (TMS-I) prepared in situ from chlorotrimethylsilane (TMS-Cl) and potassium iodide, in anhydrous acetonitrile to obtain (±)-2-benzoyloxy-7-hydroxy-6-oxo-1,2,3,4,4a,9,10,12b-octahydro [1, 4] 
, which proved also to be regioisomers (Fig. 4) , our synthesis strategy was modified. The structures of these regioisomers were distinguished by the chemical shifts of 5 0 -H Ar and 5 0 -C Ar of (±)-48, as well as 7
0 -H Ar and 7 0 -C Ar of (±)-49, because there were significant differences between the positions of these peaks both in the 1 H NMR (6.72 ppm for 5 0 -H Ar and 6.54 ppm for 7 0 -H Ar ) and 13 C NMR spectra (110.8 ppm for 5 0 -C Ar and 102.0 ppm for 7 0 -C Ar ). These diversions were due to the anisotropic shielding effect of the adjacent methoxy group in compound (±)-49, which resulted in lower chemical shifts for those aromatic hydrogen and carbon atoms at position A-7.
At first, as shown in Scheme 6, the 1:1 mixture of regioisomers (-)-42 and (-)-43 was also deacylated using the Zemplén's method resulting in (-)-6,7-dimethoxy-1,2,3,4,4a,9,10,12b-octahydro [1, 4] 
Scheme 6
and due to the regioisomer formation, two further synthetic analogues of trans-dihydronarciclasine (-)-10 and (-)-11 in moderate yields (47%).
Conclusion
In conclusion, four new synthetic trans-dihydronarciclasine analogues [(-)-8-(-)-11)] containing a relatively rigid 1,4-benzodioxane moiety in ring A were synthesised from vanillin using stereo-and enantioselective synthetic routes. These new, optically active derivatives were obtained with excellent enantiomeric purity (99% ee). According to their negative optical rotation values, these compounds appear to be new analogues of (-)-trans-dihydronarciclasine. The preparation of compounds (-)-10 and (-)-11 was due to a side reaction and regioisomer formation, and based on our modified synthesis strategy. Biological evaluations of these potentially anticancerous and antiviral molecules are in progress.
Experimental
All reagents are commercially available from Merck. Melting points were measured on a Büchi 510 apparatus using a certified mercury thermometer (ASTM 2C). Optical rotations were measured on a Perkin Elmer 241 polarimeter. IR spectra were obtained on a PerkinElmer 1600 FT-IR instrument. NMR spectra were recorded on a Bruker AV-300 instrument. HPLC analyses were carried out with a Jasco PU-1580 apparatus equipped with a Jasco UV-1575 detector (k = 256 nm) using a Daicel Chiralpack Ò OD (250 9 4.6 mm 9 5 lm) column (eluent: hexane/i-PrOH, 8:2; flow rate: 2.0 cm 3 min -1 ; 20°C). Elemental analyses were performed on a vario EL III instrument (Elementar Analysensysteme). Precoated silica gel plates (Merck 60 F 254 ) were used for analytical TLC and Kieselgel 60 for column cromatography. Compounds 14, 15, and 22 were prepared as described previously [39] , and their spectral data were found to be identical with the ones described in Ref [39] .
3,4-Dihydroxybenzaldehyde (13) A solution of 35.00 g 12 (0.23 mol) in 300 cm 3 dichloromethane was cooled to 0°C and subsequently 36.81 g AlCl 3 (0.28 mol) was added. Then it was allowed to warm to rt, 81.67 cm 3 pyridine (80.20 g, 1.01 mol) was added dropwise and the reaction mixture was refluxed for 24 h. After cooling, it was acidified with 20% aqueous hydrochloric acid to pH = 2. The precipitated pyridinium salt was dissolved by adding 300 cm 3 water and then the aqueous phase was extracted with ethyl acetate (4 9 250 cm 3 ). The combined organic layer was washed with brine, dried over Na 2 SO 4 , and evaporated in vacuo to give 29.22 g 13 (92%) as a pale yellow solid, which was used without further purification. M.p.: 152-153°C (Ref. [41] 153-154°C); its spectral data were found to be identical with the ones described in Ref. [62] .
General procedure for the synthesis of 1,4-benzodioxanes 16 and 17 43 .80 g potassium carbonate (0.32 mol) and 15.1 cm 3 1,2-dibromoethane (32.90 g, 0.18 mol) were added to a solution of 22.00 g 13 (0.16 mol) or 26.70 g 15 (0.16 mol) in 250 cm 3 DMF. The reaction mixture was stirred at 100-110°C for 4-8 h. After cooling to rt, the precipitated inorganic salts were filtered and the reaction mixture was evaporated to 80 cm 3 in vacuo. The residue was poured into 670 cm 3 water. The product was isolated as specified. 19 mol) was added 0.11 g anhydrous potassium carbonate (0.81 mmol) and the reaction mixture was refluxed for 5-8 h. Then, it was cooled to rt and 14.3 cm 3 water was added. The product was isolated as specified. General procedure for the enantioselective Michael addition using organocatalyst 22
A solution of 8.17 g 18 (40.00 mmol) or 9.37 g 19 (40.00 mmol) and 20 mol % (8S,9S)-9-amino(9-deoxy)epiquinine (22) in 54 cm 3 anhydrous nitromethane was stirred at rt for 7 d, and then the solvent was evaporated in vacuo. The residue was purified by column chromatography (hexane/EtOAc, 1:1) to obtain optically active (-)-20 or recrystallised from MeOH to give (-)-21. Spectroscopic data and elemental analysis for these compounds matched those for the racemates as given above. water was added dropwise. After separating, the aqueous phase was acidified with acetic acid to pH = 4 at 0°C. The precipitated crystals were filtered, washed with water and dried. The crude product (-)-23 or (-)-24 was purified as specified. . ( ( General procedure for the synthesis of enols (2) ( 3 anhydrous THF, and the mixture was stirred for 10 min. Then 0.47 g benzoic acid (3.85 mmol) was also added, and the reaction mixture was stirred at 0°C for 2 h, then heated to 45-50°C and further stirred for 5 h. The solvent was evaporated in vacuo and the residue was purified as specified. ( 
General procedure for acetylation
A solution of 0.99 g (?)-37 (2.22 mmol) or 1.05 g (?)-38 (2.22 mmol) in 8.28 cm 3 acetyl chloride (9.14 g, 0.12 mol) was stirred at rt for 20-24 h. Then, it was poured into 618 cm 3 saturated NaHCO 3 solution at 0°C and extracted with ethyl acetate (4 9 110 cm 3 ). The combined organic layer was washed with brine, dried over Na 2 SO 4 and concentrated in vacuo to give (-)-39 or (-)-40. General procedure for the modified BischlerNapieralski cyclisation SO 4 and evaporated in vacuo. The crude product was purified as specified.
(2)-2- Benzoyloxy-6-methoxy-1,2,3,4,4a,9 ,10,12b-octahydro [1, 4] (2)-2-Benzoyloxy-6,7-dimethoxy-1,2,3,4,4a,9,10,12b-octahydro [1, 4] (-)-2-Benzoyloxy-7-methoxy-6-oxo-1,2,3,4,4a,8,9,12b-octahydro [1, 4] 3 anhydrous tetrahydrofuran, and the reaction mixture was stirred for 2 h. Then it was poured into 500 cm 3 water and extracted with ethyl acetate (4 9 120 cm 3 ). The combined organic layer was washed with brine, dried over Na 2 SO 4 , and the solvent was evaporated in vacuo. The regioisomers were separated by column chromatography (EtOAc/ethanol, 20:1) to give (-)-50 and (-)-51.
(2)-6,7-Dimethoxy-1,2,3,4,4a,9,10,12b-octahydro [1, 4] 3 ). The combined organic layer was washed with brine, dried over Na 2 SO 4 , and the solvent was evaporated in vacuo. The crude product was purified by preparative TLC (CHCl 3 / acetone, 3:1) to afford (-)-52 or (-)-53. 83 (s, 3H, OCH 3 ), 3.53-3.45 (m, 1H, 4a-H General procedure for the selective demethylation 
